Manders D. John's Insider Trades & SAST Disclosures
Manders D. John's most recent trade in Surmodics, Inc. was a trade of 152 Common Stock done at an average price of $39.9 . Disclosure was reported to the exchange on Dec. 4, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Manders D. John.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Surmodics, Inc. | John D. Manders | VP Finance, Corp. Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.91 per share. | 04 Dec 2024 | 152 | 8,155 (0%) | 0% | 39.9 | 6,066 | Common Stock |
| Surmodics, Inc. | D. John Manders | VP Finance, Corp. Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.45 per share. | 30 Nov 2024 | 387 | 8,307 (0%) | 0% | 39.4 | 15,267 | Common Stock |
| Surmodics, Inc. | John Manders D. | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 3,160 | 3,160 | - | - | Employee Stock Option (right to buy) | |
| Surmodics, Inc. | Manders D. John | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 1,486 | 8,319 (0%) | 0% | 0 | Common Stock | |
| Surmodics, Inc. | D. John Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 212 | 6,833 (0%) | 0% | 32.8 | 6,958 | Common Stock |
| Surmodics, Inc. | Manders D. John | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 175 | 7,045 (0%) | 0% | 32.8 | 5,744 | Common Stock |
| Surmodics, Inc. | Manders D. John | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.82 per share. | 30 Nov 2023 | 68 | 7,220 (0%) | 0% | 32.8 | 2,232 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 4,810 | 4,810 | - | - | Employee Stock Option (right to buy) | |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2022 | 2,075 | 6,787 (0%) | 0% | 0 | Common Stock | |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 175 | 4,712 (0%) | 0% | 36.1 | 6,323 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.13 per share. | 30 Nov 2022 | 69 | 4,887 (0%) | 0% | 36.1 | 2,493 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.02 per share. | 25 Nov 2022 | 61 | 4,956 (0%) | 0% | 36.0 | 2,197 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 4,584 | 4,584 | - | - | Employee Stock Option (right to buy) | |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2021 | 1,707 | 4,740 (0%) | 0% | 0 | Common Stock | |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.93 per share. | 30 Nov 2021 | 68 | 3,033 (0%) | 0% | 43.9 | 2,987 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.85 per share. | 25 Nov 2021 | 61 | 3,146 (0%) | 0% | 47.9 | 2,919 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.78 per share. | 25 Nov 2021 | 45 | 3,101 (0%) | 0% | 45.8 | 2,060 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.95 per share. | 11 Aug 2021 | 2,608 | 5,716 (0%) | 0% | 23.0 | 59,854 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2021 | 2,608 | 0 | - | - | Employee Stock Option (right to buy) | |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Sale of securities on an exchange or to another person at price $ 53.33 per share. | 11 Aug 2021 | 2,555 | 3,161 (0%) | 0% | 53.3 | 136,261 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Sale of securities on an exchange or to another person at price $ 54.25 per share. | 11 Aug 2021 | 53 | 3,108 (0%) | 0% | 54.2 | 2,875 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.45 per share. | 17 Jul 2021 | 31 | 3,108 (0%) | 0% | 53.5 | 1,657 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 1,862 | 1,862 | - | - | Employee Stock Option (right to buy) | |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2020 | 667 | 3,033 (0%) | 0% | 0 | Common Stock | |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.93 per share. | 25 Nov 2020 | 61 | 2,411 (0%) | 0% | 38.9 | 2,375 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.36 per share. | 25 Nov 2020 | 45 | 2,366 (0%) | 0% | 38.4 | 1,726 | Common Stock |
| Surmodics, Inc. | John D. Manders | Corporate Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.35 per share. | 17 Jul 2020 | 31 | 2,339 (0%) | 0% | 45.4 | 1,406 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges